Electroacupuncture for acute respiratory distress
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether adding electroacupuncture to standard care helps people with acute respiratory distress syndrome (ARDS) in the ICU recover faster. If you have ARDS and are on a breathing machine, this study may be an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with sepsis (a severe infection response) and acute respiratory distress syndrome (ARDS, serious lung failure).
- You must be 18 years or older.
- You are expected to need a breathing machine for more than 48 hours.
- You are expected to stay in the ICU for more than 7 days.
- You cannot be pregnant, breastfeeding, or have a recent miscarriage.
- You cannot have severe heart, brain, liver, kidney, mental health conditions, or certain other serious illnesses.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether gentle electrical stimulation through thin needles placed in the lower legs (electroacupuncture) can help patients fight sepsis in the ICU. It aims to see if this treatment reduces organ damage and speeds recovery.
This study tests whether acupuncture can help people at high risk for sepsis, a serious infection that can lead to organ failure. If you’re 18 or older, have had a sepsis order set put in within the last two days, and are not yet in the ICU, you may be able to join.
This trial tests whether erythropoietin (EPO), a medicine that affects red blood cell production, can help clear extra fluid from the lungs in people with acute respiratory distress syndrome (ARDS). If it works, it could improve breathing and reduce lung fluid buildup during critical illness.
This trial tests a new drug called LEAF-4L6715 to see if it helps people with severe acute respiratory distress syndrome (ARDS), a serious lung condition. If you are on a breathing machine and meet the criteria below, you may be able to join.
This trial tests a new medicine called YD0743 for people who have both sepsis (a serious infection) and ARDS (a severe lung injury from the infection). The goal is to see if the medicine helps improve breathing and survival.
This trial tests whether the steroid dexamethasone can help people with sepsis who develop acute respiratory distress syndrome (ARDS), a severe lung injury. If you have an infection and need breathing support, this study may help find a better treatment.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.